NO900799L - Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym. - Google Patents
Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym.Info
- Publication number
- NO900799L NO900799L NO90900799A NO900799A NO900799L NO 900799 L NO900799 L NO 900799L NO 90900799 A NO90900799 A NO 90900799A NO 900799 A NO900799 A NO 900799A NO 900799 L NO900799 L NO 900799L
- Authority
- NO
- Norway
- Prior art keywords
- angiotens
- enzym
- concerning
- procedure
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898903888A GB8903888D0 (en) | 1989-02-21 | 1989-02-21 | Compounds |
GB898903889A GB8903889D0 (en) | 1989-02-21 | 1989-02-21 | Compounds |
GB898903887A GB8903887D0 (en) | 1989-02-21 | 1989-02-21 | Compounds |
GB898924673A GB8924673D0 (en) | 1989-11-02 | 1989-11-02 | Compounds |
GB898924674A GB8924674D0 (en) | 1989-11-02 | 1989-11-02 | Compounds |
GB898924672A GB8924672D0 (en) | 1989-11-02 | 1989-11-02 | Compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO900799D0 NO900799D0 (no) | 1990-02-20 |
NO900799L true NO900799L (no) | 1990-08-22 |
Family
ID=27547039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90900799A NO900799L (no) | 1989-02-21 | 1990-02-20 | Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0384636A1 (no) |
JP (1) | JPH02264751A (no) |
CA (1) | CA2010353A1 (no) |
FI (1) | FI900814A0 (no) |
NO (1) | NO900799L (no) |
PT (1) | PT93207A (no) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4116962A (en) * | 1976-12-03 | 1978-09-26 | E. R. Squibb & Sons, Inc. | Pyrrolidine and piperidine-2-carboxylic acid derivatives |
ZA811340B (en) * | 1980-06-09 | 1982-03-31 | Morton Norwich Products Inc | N-(cycloalkyl)amino acid compounds |
GB2090591A (en) * | 1980-12-15 | 1982-07-14 | Ici Plc | Amide derivatives |
US4440941A (en) * | 1980-12-22 | 1984-04-03 | Usv Pharmaceutical Corporation | Aroyl-aminoacids, amides and esters thereof |
US4619944A (en) * | 1981-06-01 | 1986-10-28 | Usv Pharmaceutical Corporation | Antihypertensive compounds |
IT1157268B (it) * | 1982-02-12 | 1987-02-11 | Farmatis Srl | Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo |
US4661515A (en) * | 1982-07-21 | 1987-04-28 | Usv Pharmaceutical Corporation | Compounds having angiotensin converting enzyme inhibitory activity and diuretic activity |
-
1990
- 1990-02-14 EP EP90301579A patent/EP0384636A1/en not_active Withdrawn
- 1990-02-19 CA CA002010353A patent/CA2010353A1/en not_active Abandoned
- 1990-02-19 FI FI900814A patent/FI900814A0/fi not_active Application Discontinuation
- 1990-02-20 PT PT93207A patent/PT93207A/pt not_active Application Discontinuation
- 1990-02-20 JP JP2037546A patent/JPH02264751A/ja active Pending
- 1990-02-20 NO NO90900799A patent/NO900799L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO900799D0 (no) | 1990-02-20 |
EP0384636A1 (en) | 1990-08-29 |
JPH02264751A (ja) | 1990-10-29 |
CA2010353A1 (en) | 1990-08-21 |
PT93207A (pt) | 1990-08-31 |
FI900814A0 (fi) | 1990-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO903190L (no) | Fremgangsmaate for klorering av sukrose-b-estere. | |
FI904101A0 (fi) | 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer. | |
NO903799L (no) | Acat-inhibitorer. | |
FI904729A0 (fi) | Inhibitorer av retrovirala proteaser. | |
NO884058L (no) | Fremgangsmaate for fremstilling av cefemforbindelser. | |
NO904955D0 (no) | Fremgangsmaate for fremstilling av acat-inhibitorer. | |
NO884053D0 (no) | Fremgangsmaate for fremstilling av stikkpiller. | |
NO904463D0 (no) | Korrosjonsinhibitor. | |
NO904801D0 (no) | Fremgangsmaate for fremstilling av acat-inhibitorer. | |
NO882295D0 (no) | Fremgangsmaate for fremstilling av paryledimeren. | |
DE3851877D1 (de) | Profilierungsverfahren. | |
NO894583D0 (no) | Fremgangsmaate for fremstilling av celleplast. | |
ATE119535T1 (de) | Acetylcholinesterase-inhibitoren. | |
NO892561D0 (no) | Fremgangsmaate for fremstilling av bindemidler. | |
FI101796B1 (fi) | Uusia -glukosidaasi-inhibiittoreita | |
FI902336A0 (fi) | Anordning foer framstaellning av en fristaoende kiselkristall. | |
NO901509L (no) | Fremgangsmaate for fremstilling av polyketoner. | |
NO904061D0 (no) | Fremgangsmaate for fremstilling av nmda-antagonister. | |
NO900799L (no) | Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym. | |
NO901422D0 (no) | Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer. | |
NO892761D0 (no) | Fremgangsmaate for fremstilling av inhibitorer for 3-keto-hmg-coa-reduktase. | |
NO901315D0 (no) | Fremgangsmaate for fremstilling av modifisert pe40. | |
NO892921D0 (no) | Fremgangsmaate for fremstilling av celleplast. | |
NO881843L (no) | Fremgangsmaate for fremstilling av ace-inhibitorer. | |
MX9203697A (es) | Nuevos inhibidores de acetilcolinesterase. |